Dirk Wagner
About
Dirk Wagner is a scholar working on Epidemiology, Infectious Diseases and Surgery.
According to data from OpenAlex, Dirk Wagner has authored 107 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Epidemiology, 57 papers in Infectious Diseases and 21 papers in Surgery. Recurrent topics in Dirk Wagner's work include Mycobacterium research and diagnosis (43 papers), Tuberculosis Research and Epidemiology (43 papers) and Pneumocystis jirovecii pneumonia detection and treatment (10 papers). Dirk Wagner is often cited by papers focused on Mycobacterium research and diagnosis (43 papers), Tuberculosis Research and Epidemiology (43 papers) and Pneumocystis jirovecii pneumonia detection and treatment (10 papers). Dirk Wagner collaborates with scholars based in Germany, United States and Netherlands. Dirk Wagner's co-authors include Luiz E. Bermudez, Winfried V. Kern, Norbert Schwarz, Fritz Strack, J. Mäser, Siegbert Rieg, Barry Lai, Zhonghou Cai, Kerstin Höner zu Bentrup and David G. Russell and has published in prestigious journals such as Nature Communications, The Journal of Immunology and PLoS ONE.
In The Last Decade
Dirk Wagner
100 papers receiving 3.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Dirk Wagner Germany | 33 | 1.9k | 1.7k | 592 | 579 | 438 | 107 | 3.9k | ||
| Robertino M. Mera United States | 44 | 1.3k 0.7× | 1.4k 0.9× | 484 0.8× | 1.8k 3.2× | 677 1.5× | 252 | 6.0k | ||
| Payam Tabarsi Iran | 34 | 3.0k 1.6× | 1.9k 1.2× | 623 1.1× | 893 1.5× | 632 1.4× | 302 | 5.1k | ||
| Shmuel Shoham United States | 33 | 2.8k 1.5× | 2.3k 1.4× | 480 0.8× | 279 0.5× | 360 0.8× | 108 | 4.9k | ||
| José A. Pérez‐Molina Spain | 38 | 1.8k 1.0× | 2.6k 1.6× | 519 0.9× | 244 0.4× | 488 1.1× | 199 | 5.9k | ||
| Kenji Hirayama Japan | 45 | 1.3k 0.7× | 1.1k 0.7× | 305 0.5× | 365 0.6× | 851 1.9× | 266 | 6.4k | ||
| Alberto Paniz‐Mondolfi United States | 28 | 1.9k 1.0× | 883 0.5× | 851 1.4× | 324 0.6× | 458 1.0× | 143 | 3.6k | ||
| Andrea Sylvia Winkler Germany | 37 | 737 0.4× | 574 0.3× | 673 1.1× | 677 1.2× | 330 0.8× | 196 | 4.5k | ||
| Melchor Álvarez‐Mon Spain | 44 | 807 0.4× | 2.3k 1.4× | 195 0.3× | 1.2k 2.0× | 1.7k 3.9× | 347 | 8.9k | ||
| James C. Johnston Canada | 31 | 2.7k 1.5× | 1.9k 1.1× | 346 0.6× | 904 1.6× | 651 1.5× | 133 | 5.1k | ||
| J. Kenneth Baillie United Kingdom | 35 | 2.8k 1.5× | 941 0.6× | 1.3k 2.1× | 269 0.5× | 1.7k 3.8× | 117 | 7.2k |
Countries citing papers authored by Dirk Wagner
Since
Specialization
Citations
This map shows the geographic impact of Dirk Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Wagner more than expected).
Fields of papers citing papers by Dirk Wagner
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Dirk Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Wagner. The network helps show where Dirk Wagner may publish in the future.
Co-authorship network of co-authors of Dirk Wagner
This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Wagner. A scholar is included among the top collaborators of Dirk Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Wagner. Dirk Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Pinheiro, Marina, Onno W. Akkerman, Timothy R. Aksamit, et al.. (2025). Consensus on the management of refractory nontuberculous mycobacterial pulmonary disease. European Respiratory Journal. 67(1). 2500400–2500400.
2.
Morimoto, Kozo, Jack R. Gallagher, Dirk Wagner, David E. Griffith, & Jakko van Ingen. (2024). Real-World Patients’ Diagnosis-to-Treatment Journey with Nontuberculous Mycobacterial Pulmonary Disease: A Cross-Sectional Survey. Infectious Diseases and Therapy. 13(8). 1907–1920.
3.
Loebinger, Michael R., Stefano Aliberti, Charles Haworth, et al.. (2024). Patients at risk of nontuberculous mycobacterial pulmonary disease who need testing evaluated using a modified Delphi process by European experts. ERJ Open Research. 10(5). 791–2023.
4.
Aliberti, Stefano, Francesco Blasi, Pierre‐Régis Burgel, et al.. (2024). Mycobacterium aviumcomplex pulmonary disease patients with limited treatment options. ERJ Open Research. 10(1). 610–2023.
5.
Prevots, D. Rebecca, et al.. (2023). Global Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease. Clinics in Chest Medicine. 44(4). 675–721.
6.
Schneider, Johanna, et al.. (2023). Nirmatrelvir/ritonavir treatment in SARS-CoV-2 positive kidney transplant recipients – a case series with four patients. BMC Nephrology. 24(1). 99–99.
7.
Mbakaya, Balwani Chingatichifwe, et al.. (2023). Acceptability and feasibility of tuberculosis and diabetes mellitus bidirectional screening and joint treatment services in Malawi: a cross-sectional study and a policy document review. BMJ Open. 13(1). e062009–e062009.
8.
Wagner, Dirk, et al.. (2022). Effect of Tuberculosis (TB) and Diabetes mellitus (DM) integrated healthcare on bidirectional screening and treatment outcomes among TB patients and people living with DM in developing countries: a systematic review. Pathogens and Global Health. 117(1). 36–51.
9.
Lang‐Meli, Julia, Jonas Fuchs, Hsi-en Ho, et al.. (2021). Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency. Journal of Clinical Immunology. 42(2). 253–265.
10.
Dreßing, Andrea, Tobias Bormann, Ganna Blazhenets, et al.. (2021). Neuropsychologic Profiles and Cerebral Glucose Metabolism in Neurocognitive Long COVID Syndrome. Journal of Nuclear Medicine. 63(7). 1058–1063.
11.
Schildkraut, Jodie A., Jack R. Gallagher, Kozo Morimoto, et al.. (2020). Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation. Respiratory Medicine. 173. 106164–106164.
12.
Wagner, Dirk, Jakko van Ingen, Roald van der Laan, & M Obradović. (2020). Non-tuberculous mycobacterial lung disease in patients with bronchiectasis: perceived risk, severity and guideline adherence in a European physician survey. BMJ Open Respiratory Research. 7(1). e000498–e000498.
13.
Rowland, Bosco, Charles Abraham, Rob Carter, et al.. (2018). Trial protocol: a clustered, randomised, longitudinal, type 2 translational trial of alcohol consumption and alcohol-related harm among adolescents in Australia. BMC Public Health. 18(1). 559–559.
14.
Wagner, Dirk, Jakko van Ingen, Jennifer Adjemian, et al.. (2014). Annual prevalence and treatment estimates of nontuberculous mycobacterial pulmonary disease in Europe: A NTM-NET collaborative study. European Respiratory Journal. 44(Suppl 58). P1067–P1067.
15.
Ingen, Jakko van, Jennifer Adjemian, Kozo Morimoto, et al.. (2014). Comparison of treatment practices for nontuberculous mycobacterial pulmonary disease in Japan, Europe, and United States. European Respiratory Journal. 44(Suppl 58). P1066–P1066.
16.
Breuninger, Marianne, Bram van Ginneken, Rick H. H. M. Philipsen, et al.. (2014). Diagnostic Accuracy of Computer-Aided Detection of Pulmonary Tuberculosis in Chest Radiographs: A Validation Study from Sub-Saharan Africa. PLoS ONE. 9(9). e106381–e106381.
17.
Lange, Berit, Martina Vavra, Winfried V. Kern, & Dirk Wagner. (2011). IP-10 measurement using a point of care test for the diagnosis of active tuberculosis. European Respiratory Journal. 38(Suppl 55). 1900–1900.
18.
Wagner, Dirk, et al.. (2008). Vergleich von Tuberkulin-Hauttests und Interferon-Gamma-Tests im Rahmen einer Umgebungsuntersuchung in einer JVA. Das Gesundheitswesen. 70(11). 684–689.
19.
Wagner, Dirk, J. Mäser, Barry Lai, et al.. (2005). Elemental Analysis of Mycobacterium avium -, Mycobacterium tuberculosis -, and Mycobacterium smegmatis -Containing Phagosomes Indicates Pathogen-Induced Microenvironments within the Host Cell’s Endosomal System. The Journal of Immunology. 174(3). 1491–1500.
20.
Gross, Gerd, et al.. (1985). [Bowenoid papulosis and carcinoma in situ of the cervix uteri in sex partners. An example of the transmissibility of HPV-16 infection].. PubMed. 36(8). 465–9.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Robertino M. Mera Breakdown of academic impact, for papers by Payam Tabarsi Breakdown of academic impact, for papers by Shmuel Shoham Breakdown of academic impact, for papers by José A. Pérez‐Molina Breakdown of academic impact, for papers by Kenji Hirayama Breakdown of academic impact, for papers by Alberto Paniz‐Mondolfi Breakdown of academic impact, for papers by Andrea Sylvia Winkler Breakdown of academic impact, for papers by Melchor Álvarez‐Mon Breakdown of academic impact, for papers by James C. Johnston Breakdown of academic impact, for papers by J. Kenneth Baillie